Skip to main content
Clinical Trials/NCT01075893
NCT01075893
Completed
Not Applicable

Changes in Stem Cells of the Colon in Response to Increased Risk of Colorectal Cancer

Newcastle University2 sites in 1 country11 target enrollmentFebruary 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Colorectal Cancer
Sponsor
Newcastle University
Enrollment
11
Locations
2
Primary Endpoint
Number of stem cells in the colonic crypt
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Colorectal cancer is a common disease worldwide. Increasing evidence is demonstrating that colorectal cancers arise from 'cancer stem cells.' Stem cells in the colon reside at the bottom of thousands of microscopic crypts throughout the wall of the colon. They create all the cells lining the bowel wall. These cells are created in the base of the crypt and ascend to the top acquiring the characteristics of mature cells of the bowel wall as they ascend.

It is now thought that colorectal cancer cells arise from stem cells where the genetic material regulating growth and division of the stem cell has become defective. This leads to unregulated production of cells which in turn have defective genetic information and cancer formation.

Prior studies have demonstrated that the earliest changes before a cancer develops are changes in cellular proliferation. Now that reliable markers to identify stem cells have been found, the researchers aim to investigate stem cell numbers and changes in distribution in those at normal risk of colorectal cancer and those at higher risk. The researchers hypothesise that changes in cellular proliferation at the top of the crypt in individuals at higher risk of colorectal cancer are due to a change in the number of stem cells in the crypt base.

Registry
clinicaltrials.gov
Start Date
February 2010
End Date
October 2012
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Referred for endoscopy at participating centre

Exclusion Criteria

  • Age \<16 or \>85
  • Familial polyposis syndrome
  • Lynch syndrome
  • Known colorectal tumour
  • Previous colorectal resection
  • Pregnancy
  • Chemotherapy in last 6 months
  • Therapy with aspirin/other nonsteroidal anti-inflammatory drug (NSAID)
  • Other immunosuppressive medication
  • Incomplete left sided examination

Outcomes

Primary Outcomes

Number of stem cells in the colonic crypt

Time Frame: On day of endoscopy

Secondary Outcomes

  • Stem cell position in colonic crypt(On day of endoscopy)

Study Sites (2)

Loading locations...

Similar Trials